Antimicrobial drug-selection markers for Burkholderia pseudomallei and B. mallei

Herbert P. Schweizer, Sharon J. Peacock

Research output: Contribution to journalReview articlepeer-review

15 Citations (Scopus)

Abstract

Genetic research into the select agents Burkholderia pseudomallei and B. mallei is currently hampered by a paucity of approved antimicrobial drug-selection markers. The strict regulations imposed on researchers in the United States but not in other parts of the world lead to discrepancies in practice, hinder distribution of genetically modified strains, and impede progress in the field. Deliberation and decisions regarding alternative selection markers (antimicrobial and nonantimicrobial drugs) by the international community, regulatory authorities, and funding agencies are needed.

Original languageEnglish
Pages (from-to)1689-1692
Number of pages4
JournalEmerging Infectious Diseases
Volume14
Issue number11
DOIs
Publication statusPublished - Nov 2008
Externally publishedYes

Fingerprint

Dive into the research topics of 'Antimicrobial drug-selection markers for Burkholderia pseudomallei and B. mallei'. Together they form a unique fingerprint.

Cite this